Tolentino, Primo E.

HRN: 27-19-56  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2026
ACICLOVIR 800MG (TAB)
05/10/2026
05/17/2026
PO
800mg
Q6
Herpes Zoster
Checking Initial Appropriateness 
05/10/2026
CLINDAMYCIN 300MG (CAP)
05/10/2026
05/17/2026
PO
300mg
Q6
HERPES ZOSTER
Checking Initial Appropriateness 
05/10/2026
MUPIROCIN 2%, 15G (TUBE)
05/10/2026
05/17/2026
TOPICAL
15g
BID
Herpes Zoster
Checking Initial Appropriateness 
05/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/10/2026
05/17/2026
IV
2g
Q8
Herpes Zoster
Checking Initial Appropriateness 
05/10/2026
CLINDAMYCIN 300MG (CAP)
05/10/2026
05/17/2026
PO
600mg
Q6
Herpes Zoster
Checking Initial Appropriateness 
05/10/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/10/2026
05/17/2026
IV
600mg
Q6
Herpes Zoster
Checking Initial Appropriateness 
05/10/2026
ACICLOVIR 800MG (TAB)
05/10/2026
05/17/2026
PO
800mg
Q4
Herpes Zoster
Checking Initial Appropriateness 
05/12/2026
CLINDAMYCIN 300MG (CAP)
05/12/2026
05/17/2026
PO
300mg
Q6
Herpes Zoster
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: